share_log

Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate

Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate

Heart Test Laboratories 第二季度每股收益 $(2.27) 超过 $(2.43) 预期
Benzinga ·  2024/12/17 05:25

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(2.43) by 6.58 percent. This is a 85.74 percent increase over losses of $(15.92) per share from the same period last year.

心脏测试实验室(纳斯达克:HSCS)报告了季度每股亏损$(2.27),超出了分析师共识预期的$(2.43) ,相差6.58%。与去年同期每股亏损$(15.92)相比,亏损增加了85.74%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发